TheraBiogen Inc.launches the highly anticipated product TheraMax Cold and Flu

Nov. 30, 2011 - PRLog -- November 30, 2011

Contact:  Megale Public Relations at (347) 92-STARS or (347) 927-8277 E Mail: info@mediaproductions.tv

TheraBiogen Inc.launches the highly anticipated product TheraMax Cold and Flu

(New York, NY) -Megale Public Relations is pleased to announce its partnership with TheraBiogen Inc. (TRAB:OTCBB) in the launch of TheraBiogen's homeopathic product, TheraMax™ Cold and Flu.  It will directly challenge the formulation of Zicam™ in the Cold and Flu industry, putting to rest concerns of medical benefit while avoiding the side effects of zinc.  TheraMax™ Cold and Flu is currently sold by two of the three largest retail pharmacy giants and a number of other retailers.

TheraMaxtm offers a better non-zinc alternative to cold and flu medications known to cause adverse side effects, especially with use of nasal sprays.  TheraMax™ Cold and Flu is an all-natural, non-addictive, over-the-counter cold and flu relief agent which aids in relief to cold and flu sufferers.

"As was the case in years prior, the potential shortage of flu vaccines and those that wish not to be inoculated," comments Megan Megale, President of Megale Public Relations, "TheraMax™ offers an effective alternative in treating the symptoms of the flu. The estimated $112 million dollar market segment opportunity for nasal spray products, which is now open due to the withdrawal of other nasal spray products from the marketplace, is in our opinion, available to TheraMax™. We couldn't be more excited to be a part of this project.  TheraMax™ is a quantum leap in cold and flu relief."

The product is currently sold in over 12,000 locations in the U.S.  With over 50 million Americans contracting the flu each year, consumer demand for a homeopathic, non-zinc remedy in the 2.5 billion dollar market for cold and flu products, TheraMax™ could become the preferred product for over-the-counter medications.


Megale Public Relations will be implementing a global strategy, inclusive of media relations, product integration, co-branding opportunities and celebrity seeding complimented with a dynamic advertising campaign.  


The product is a homeopathic remedy of ingredients pre-approved by the FDA (Food and Drug Administration). Independent studies suggest the product provides temporary relief of common cold and flu ailments such as sneezing, runny nose, itchy/watery eyes, nasal congestion, and sinus pressure.  


Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the TheraBiogen, Inc.'s most recently filed Form 10-K and Form 10-Q reports. TheraBiogen, Inc. assumes no obligation to update the statements contained in this release except as required by applicable securities laws disclosure rules.

TheraMax is available for interviews. Please contact Megale Public Relations, Shannon Rose, at (347) 92-STARS or (347) 927-8277, Email: info@mediaproductions.tv

# # #

Eclectic Media Productions has provided top quality public relations for a variety of clientele throughout the country. From entertainment star Danny Bonaduce to national radio host Chris Markowski.